We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Light-Activated Drug Transport System Based on RBC Carriers

By LabMedica International staff writers
Posted on 18 Jan 2017
Print article
Image: A scanning electron micrograph (SEM) image of human red blood cells (Photo courtesy of MPI).
Image: A scanning electron micrograph (SEM) image of human red blood cells (Photo courtesy of MPI).
A novel system for precise delivery of toxic anticancer drugs is based on the use of red blood cells as carriers to transport immobilized drug complexes that are released at specific sites upon exposure to light.

Investigators at the University of North Carolina found that membrane-permeable drugs could be rendered membrane impermeable by covalent attachment to cobalamin (Cbl) through a photocleavable linker. These Cbl-drug conjugates could be trapped within lipid-enclosed compartments in the dark. The investigators adapted red blood cells for this purpose. Subsequent exposure to light broke the Cbl-drug bond and enabled the secretion of the bioactive species from the red blood cells.

The investigators reported in the December 23, 2016, issue of the journal Angewandte Chemie that photorelease of the trapped drug was triggered by wavelengths in the red, far-red, and near-IR regions, which could be pre-assigned by affixing a fluorophore with the desired excitation wavelength to the Cbl-drug conjugate. Breaking the weak energy bond between vitamin B12 and the drug was facilitated by the attached fluorescent molecule, which captured and focused the long wavelength light that ultimately cut the bond between the drug and the vitamin carrier.

"The problem is when you start using four or five very toxic drugs you are going to have intolerable side effects," said senior author Dr. David Lawrence, professor of pharmacy at the University of North Carolina. "However, by focusing powerful drugs at a specific site, it may be possible to significantly reduce or eliminate the side effects that commonly accompany cancer chemotherapy. Using light to treat a disease site has a lot of benefits beyond the "is not-that-cool" factor. Those benefits could include avoiding surgery and the risk of infection, making anesthesia unnecessary and allowing people to treat themselves by shining a light on a problem area, such as an arthritic knee."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.